Inventor · disambiguated record
Daniel T. Macleod
Also filed as: MACLEOD DANIEL · MACLEOD DANIEL T
14 granted patents·14 pending applications·197 citations·filing 2016–2024
94Inventor score
Top patents by PatentIndex Score
28 records- 0198US9889161B2Genetically-modified cells comprising a modified human T cell receptor alpha constant region genePREC BIOSCIENCES INC·Filed 2017·Granted Feb 13, 2018·27 cites·4 claims
- 0298US9889160B2Genetically-modified cells comprising a modified human T cell receptor alpha constant region genePREC BIOSCIENCES INC·Filed 2017·Granted Feb 13, 2018·65 cites·9 claims
- 0397US10093900B2Genetically-modified cells comprising a modified human T cell receptor alpha constant region genePREC BIOSCIENCES INC·Filed 2018·Granted Oct 9, 2018·15 cites·9 claims
- 0497US9993501B2Genetically-modified cells comprising a modified human T cell receptor alpha constant region genePREC BIOSCIENCES INC·Filed 2018·Granted Jun 12, 2018·11 cites·13 claims
- 0597US9993502B1Genetically-modified cells comprising a modified human T cell receptor alpha constant region genePREC BIOSCIENCES INC·Filed 2018·Granted Jun 12, 2018·16 cites·13 claims
- 0697US9969975B1Genetically-modified cells comprising a modified human T cell receptor alpha constant region genePREC BIOSCIENCES INC·Filed 2018·Granted May 15, 2018·13 cites·9 claims
- 0797US9950010B1Genetically-modified cells comprising a modified human T cell receptor alpha constant region genePREC BIOSCIENCES INC·Filed 2018·Granted Apr 24, 2018·14 cites·8 claims
- 0897US9950011B1Genetically-modified cells comprising a modified human T cell receptor alpha constant region genePREC BIOSCIENCES INC·Filed 2018·Granted Apr 24, 2018·14 cites·8 claims
- 0995US10800833B2Co-stimulatory domains for use in genetically-modified cellsPREC BIOSCIENCES INC·Filed 2019·Granted Oct 13, 2020·7 cites·23 claims
- 1094US10093899B1Genetically-modified cells comprising a modified human T cell receptor alpha constant region genePREC BIOSCIENCES INC·Filed 2018·Granted Oct 9, 2018·8 cites·9 claims
- 1193US10799535B2Engineered meganucleases with recognition sequences found in the human T cell receptor alpha constant region genePREC BIOSCIENCES INC·Filed 2016·Granted Oct 13, 2020·5 cites·5 claims
- 1287US2024002796A1Genetically-modified cells comprising a modified human t cell receptor alpha constant region genePREC BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1385US11286291B2Co-stimulatory domains for use in genetically-modified cellsPREC BIOSCIENCES INC·Filed 2017·Granted Mar 29, 2022·2 cites·28 claims
- 1485US2024382526A1Nucleic acids encoding engineered meganucleases with recognition sequences found in the human t cell receptor alpha constant region genePREC BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 1582US2024018215A1Co-stimulatory domains for use in genetically-modified cellsPREC BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1682US2022135945A1Genetically-modified cells comprising a modified human t cell receptor alpha constant region genePREC BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1782US2022145251A1Genetically-modified cells comprising a modified human t cell receptor alpha constant region genePREC BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1879US11268065B2Genetically-modified cells comprising a modified human T cell receptor alpha constant region genePREC BIOSCIENCES INC·Filed 2021·Granted Mar 8, 2022·0 cites·17 claims
- 1975US2022152112A1Nucleic acids encoding engineered meganucleases with recognition sequences found in the human t cell receptor alpha constant region genePREC BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2073US11266693B2Nucleic acids encoding engineered meganucleases with recognition sequences found in the human T cell receptor alpha constant region genePREC BIOSCIENCES INC·Filed 2020·Granted Mar 8, 2022·0 cites·9 claims
- 2172US2019194616A1Genetically-modified cells comprising a modified human t cell receptor alpha constant region genePREC BIOSCIENCES INC·Filed 2018·Application pending·0 cites
- 2270US2023174621A1Modified epidermal growth factor receptor peptides for use in genetically-modified cellsPREC BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2369US2020399346A1Co-stimulatory domains for use in genetically-modified cellsPREC BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 2461US2020239544A1Modified epidermal growth factor receptor peptides for use in genetically-modified cellsPREC BIOSCIENCES INC·Filed 2018·Application pending·0 cites
- 2555US2025262242A1Human t cell receptors specific for antigenic peptides derived from mitogen-activated protein kinase 8 interacting protein 2 (mapk8ip2), epstein-barr virus or human endogenous retrovirus, and uses thereofIMMUNOSCAPE PTE LTD·Filed 2023·Application pending·0 cites
- 2655US2023190780A1Methods for immunotherapyPREC BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 2753US2023036065A1Methods for cancer immunotherapyPREC BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 2853US2022411479A1Cd20 chimeric antigen receptors and methods of use for immunotherapyPREC BIOSCIENCES INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daniel T. Macleod files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →